University of California San Francisco

Give to UCSF
Advanced
2864 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Antibody Network Partners With Celgene for Cancer Therapies

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.

Placeholder image

Crunching Numbers to Combat Cancer

UCSF has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer.

Lessons From History To Improve Drug Ads For Consumers

In a perspective published by the New England Journal of Medicine, UCSF's Elizabeth Watkins shares a historical perspective of pharmaceutical advertising and proposes a new approach for educating consumers.

24-Hour OBs, Midwives Lead to Less C-Sections

Privately insured pregnant women are less likely to have C-sections when their regular care includes midwives and 24-hour obstetrician coverage, according to a study by researchers at UCSF and Marin General Hospital.

Placeholder image

Shouldering the Burden of Evolution

As early humans took an evolutionary step away from apes, what this last common ancestor with apes looked like has remained unclear. A new study led by researchers at UCSF shows that important clues lie in the shoulder.

Placeholder image

Next-Gen Genomic Tests Identify Brain-Eating Amoeba

Rapid next-generation genomic sequencing helped identify a mysterious brain-eating amoeba that killed a patient, and a new UCSF center aims to make this test an affordable and available tool for more hospitals.

Rare Melanoma Carries Unprecedented Burden of Mutations

A rare, deadly form of skin cancer known as desmoplasmic melanoma may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UCSF scientists.

Placeholder image